Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

UCB 35625

Known as: J113863, J 113863, UCB35625 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
In the present study, we characterize the antinociceptive effects produced by the chemokine CCL4 in mice. The intraplantar… Expand
2017
2017
We show here that the intraplantar administration of CCL5 in mice produces hyperalgesia at low doses but activates compensatory… Expand
2016
2016
Chemokines are chemotactic cytokines whose involvement in nociceptive processing is being increasingly recognized. Based on the… Expand
2016
2016
Biased agonism at G protein-coupled receptors constitutes a promising area of research for the identification of new therapeutic… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2014
2014
Although the expression of the chemokine receptor CCR1 has been demonstrated in several structures related to nociception… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2013
Highly Cited
2013
The antineoplastic paclitaxel induces a sensory neuropathy that involves the spinal release of neuroinflammatory mediators and… Expand
2007
2007
Chemokine receptor CCR3 is highly expressed by eosinophils and signals in response to binding of the eotaxin family of chemokines… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
2006
Highly Cited
2006
The chemokine receptor CCR1 is a potential target for the treatment of rheumatoid arthritis. To explore the impact of CCR1… Expand
Highly Cited
2004
Highly Cited
2004
Interactions between proinflammatory and cell maturation signals, and the pathways that regulate leukocyte migration, are of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2000
Highly Cited
2000
We describe a small molecule chemokine receptor antagonist, UCB35625 (the trans-isomer J113863 published by Banyu Pharmaceutical… Expand